@article{atak_pigmented_2022,
	title = {Pigmented purpuric dermatosis after {BNT162B2} {mRNA} {COVID}-19 vaccine administration},
	volume = {21},
	copyright = {All rights reserved},
	issn = {1473-2165},
	url = {http://www.ncbi.nlm.nih.gov/pubmed/34791786},
	doi = {10.1111/jocd.14607},
	language = {eng},
	number = {2},
	journal = {Journal of Cosmetic Dermatology},
	author = {Atak, Mehmet Fatih and Farabi, Banu and Kalelioglu, Mehmet Berati and Rao, Babar K.},
	month = feb,
	year = {2022},
	keywords = {BNT162 Vaccine, BNT162B2 mRNA vaccine, COVID-19, COVID-19 Vaccines, COVID-19 vaccine, Humans, Pigmentation Disorders, RNA, Messenger, SARS-CoV-2, Schamber disease, cutaneous adverse event, pigmented purpuric dermatosis},
	pages = {435--437},
}

{"_id":"aXmWz9F8bPryqw4rp","bibbaseid":"atak-farabi-kalelioglu-rao-pigmentedpurpuricdermatosisafterbnt162b2mrnacovid19vaccineadministration-2022","author_short":["Atak, M. F.","Farabi, B.","Kalelioglu, M. B.","Rao, B. K."],"bibdata":{"bibtype":"article","type":"article","title":"Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administration","volume":"21","copyright":"All rights reserved","issn":"1473-2165","url":"http://www.ncbi.nlm.nih.gov/pubmed/34791786","doi":"10.1111/jocd.14607","language":"eng","number":"2","journal":"Journal of Cosmetic Dermatology","author":[{"propositions":[],"lastnames":["Atak"],"firstnames":["Mehmet","Fatih"],"suffixes":[]},{"propositions":[],"lastnames":["Farabi"],"firstnames":["Banu"],"suffixes":[]},{"propositions":[],"lastnames":["Kalelioglu"],"firstnames":["Mehmet","Berati"],"suffixes":[]},{"propositions":[],"lastnames":["Rao"],"firstnames":["Babar","K."],"suffixes":[]}],"month":"February","year":"2022","keywords":"BNT162 Vaccine, BNT162B2 mRNA vaccine, COVID-19, COVID-19 Vaccines, COVID-19 vaccine, Humans, Pigmentation Disorders, RNA, Messenger, SARS-CoV-2, Schamber disease, cutaneous adverse event, pigmented purpuric dermatosis","pages":"435–437","bibtex":"@article{atak_pigmented_2022,\n\ttitle = {Pigmented purpuric dermatosis after {BNT162B2} {mRNA} {COVID}-19 vaccine administration},\n\tvolume = {21},\n\tcopyright = {All rights reserved},\n\tissn = {1473-2165},\n\turl = {http://www.ncbi.nlm.nih.gov/pubmed/34791786},\n\tdoi = {10.1111/jocd.14607},\n\tlanguage = {eng},\n\tnumber = {2},\n\tjournal = {Journal of Cosmetic Dermatology},\n\tauthor = {Atak, Mehmet Fatih and Farabi, Banu and Kalelioglu, Mehmet Berati and Rao, Babar K.},\n\tmonth = feb,\n\tyear = {2022},\n\tkeywords = {BNT162 Vaccine, BNT162B2 mRNA vaccine, COVID-19, COVID-19 Vaccines, COVID-19 vaccine, Humans, Pigmentation Disorders, RNA, Messenger, SARS-CoV-2, Schamber disease, cutaneous adverse event, pigmented purpuric dermatosis},\n\tpages = {435--437},\n}\n\n\n\n","author_short":["Atak, M. F.","Farabi, B.","Kalelioglu, M. B.","Rao, B. K."],"key":"atak_pigmented_2022","id":"atak_pigmented_2022","bibbaseid":"atak-farabi-kalelioglu-rao-pigmentedpurpuricdermatosisafterbnt162b2mrnacovid19vaccineadministration-2022","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/34791786"},"keyword":["BNT162 Vaccine","BNT162B2 mRNA vaccine","COVID-19","COVID-19 Vaccines","COVID-19 vaccine","Humans","Pigmentation Disorders","RNA","Messenger","SARS-CoV-2","Schamber disease","cutaneous adverse event","pigmented purpuric dermatosis"],"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/raoresearch","dataSources":["5i38dLwPk6C3jurSL","aGgndugSyribdb2rd","2tgmyzKov4y6MHvQs"],"keywords":["bnt162 vaccine","bnt162b2 mrna vaccine","covid-19","covid-19 vaccines","covid-19 vaccine","humans","pigmentation disorders","rna","messenger","sars-cov-2","schamber disease","cutaneous adverse event","pigmented purpuric dermatosis"],"search_terms":["pigmented","purpuric","dermatosis","bnt162b2","mrna","covid","vaccine","administration","atak","farabi","kalelioglu","rao"],"title":"Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administration","year":2022}